These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5128893)

  • 21. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-oxygen affinity and sickling in sickle cell disease: effect of prior deoxygenation.
    Sinet M; Pocidalo JJ
    J Lab Clin Med; 1981 Oct; 98(4):492-9. PubMed ID: 6793678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of sickling in vitro by sodium naproxen.
    Rooks WH; Kennedy C; Glenn O; Carter A
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):421-2. PubMed ID: 4852483
    [No Abstract]   [Full Text] [Related]  

  • 24. Arterial blood pressure and hyperviscosity in sickle cell disease.
    Johnson CS
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):827-37, vi. PubMed ID: 16214646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in-vitro inhibition of erythrocyte sickling by Biuret.
    Photiades DP; Khalil SA; Osamo NO; Obi JO
    Blut; 1974 Sep; 29(3):219-23. PubMed ID: 4416306
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of sickling in erythrocytes by amino acids.
    Rumen NM
    Blood; 1975 Jan; 45(1):45-8. PubMed ID: 803109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane-bound hemoglobin in the erythrocytes of sickle cell anemia.
    Sears DA; Luthra MG
    J Lab Clin Med; 1983 Nov; 102(5):694-8. PubMed ID: 6631167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods of the estimation of acetylcholinesterase activity in the erythrocytes of laboratory animals given carbamates or organophosphorus compounds.
    Pickering RG; Pickering CE
    Arch Toxikol; 1974 Feb; 31(3):197-216. PubMed ID: 4826866
    [No Abstract]   [Full Text] [Related]  

  • 29. Dehydration and delayed proton equilibria of red blood cells suspended in isosmotic phosphate buffers. Implications for studies of sickled cells.
    Bookchin RM; Lew DJ; Balazs T; Ueda Y; Lew VL
    J Lab Clin Med; 1984 Dec; 104(6):855-66. PubMed ID: 6094692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between morphologic characteristics of sickle cells and method of deoxygenation.
    Asakura T; Mayberry J
    J Lab Clin Med; 1984 Dec; 104(6):987-94. PubMed ID: 6502005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homoserine inhibition of in vitro sickling of erythrocytes.
    Kang SS; Benjamin G
    Exp Mol Pathol; 1975 Apr; 22(2):220-4. PubMed ID: 1116571
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of sickling by methyl acetimidate.
    Chao TL; Berenfeld MR; Gabuzda TG
    FEBS Lett; 1976 Feb; 62(1):57-9. PubMed ID: 1248638
    [No Abstract]   [Full Text] [Related]  

  • 34. Sickle cell shape and structure: images and concepts (1840-1980).
    Bessis M; Delpech G
    Blood Cells; 1982; 8(2):359-435. PubMed ID: 6760930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
    Thurston GB; Henderson NM; Jeng M
    Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of sickling after reduction of intracellular hemoglobin concentration with an osmotic pulse: characterization of the density and hemoglobin concentration distributions.
    Franco RS; Barker-Gear R; Green R
    Blood Cells; 1993; 19(2):475-88; discussion 489-91. PubMed ID: 8312575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of sickle cell anemia with induced hyponatremia.
    Rosa RM; Bierer BE; Bunn HF; Epstein FH
    Blood Cells; 1982; 8(2):329-35. PubMed ID: 7159756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic strategies for prevention of sickle cell dehydration.
    Brugnara C
    Blood Cells Mol Dis; 2001; 27(1):71-80. PubMed ID: 11358364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocyte aging in sickle cell disease.
    Bosman GJ
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):81-6. PubMed ID: 15040431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyamines and globin binding in sickle cell disease.
    Natta CL; Motyczka AA; Kremzner LT
    Am J Pediatr Hematol Oncol; 1982; 4(1):73-6. PubMed ID: 7091579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.